Cleared Abbreviated

Insupen Pen needle, Insupen ORIGINAL Pen Needle, Insupen ADVANCED pen needle (K203792) - FDA 510(k) Clearance

Class II General Hospital device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K203792 · Pikdare Spa · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
753d
Days
Class 2
Risk

K203792 is an FDA 510(k) clearance for the Insupen Pen needle, Insupen ORIGINAL Pen Needle, Insupen ADVANCED pen needle. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Pikdare Spa (Casnate Con Bernate, IT). The FDA issued a Cleared decision on January 20, 2023 after a review of 753 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Pikdare Spa devices

Submission Details

510(k) Number K203792 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 28, 2020
Decision Date January 20, 2023
Days to Decision 753 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
624d slower than avg
Panel avg: 129d · This submission: 753d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 196
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K203792.
Shina Safety Needle
K222417 · Shina Corporation · Mar 2023
Sterile Aesthetic Cannula and Hypodermic Needle
K223327 · Shanghai Kindly Enterprise Development Group Co., Ltd. · Feb 2023
Verisafe Safety sterile needles
K222271 · Promisemed Hangzhou Meditech Co., Ltd. · Feb 2023
BD AutoShield Duo™ Pen Needle
K223286 · Becton, Dickinson and Company · Dec 2022
Sterile Hypodermic Needles for Single Use
K223334 · Zhejiang Kindly Medical Devices Co., Ltd. · Dec 2022
CCBIO ASCPO Needle
K214004 · Cc Biotechnology Corporation · Dec 2022